pharma news

News

GSK hails 'unprecedented' cure rates with hep B drug

The B-Well trials of GSK's bepirovirsen position the antisense drug as a "major step towards a cure for hepatitis B infection," according to experts.

News

EpiWatch app detects major seizures with few false alarms

An Apple Watch patient monitoring app can help people with epilepsy reduce the risk of sudden death, with high sensitivity and a low false alarm rate.

News

November date set for FDA decision on Sanofi's Gaucher drug

The FDA has started a priority review of Sanofi's brain-acting Gaucher disease therapy venglustat, with an action date of 25th November.

News

AbbVie's Immunogen buy delivers rare cancer drug approval

AbbVie's Decnupaz approval will give patients with rare blood cancer BPDCN an alternative to Stemline's Elzonris with a simpler dosing regimen.

News

Zuckerberg, Chan's Biohub launches protein 'world model'

Chan Zuckberg Initiative-backed Biohub has made what it says is an AI-powered "world model" of protein biology available freely to researchers.

News

FDA delays verdict on AZ breast cancer drug

After an advisory committee setback, AstraZeneca has a chance to make the case for its oral SERD camizestrant for breast cancer.

GSK hails 'unprecedented' cure rates with hep B drug

EpiWatch app detects major seizures with few false alarms

November date set for FDA decision on Sanofi's Gaucher drug

AbbVie's Immunogen buy delivers rare cancer drug approval

Zuckerberg, Chan's Biohub launches protein 'world model'

FDA delays verdict on AZ breast cancer drug

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks